NEW YORK, June 21 (GenomeWeb News) - GE Healthcare said today that the Paris-based Institut Curie will use its IN Cell Analyzer 1000 sub-cellular imaging system for a new research project.
The study, called the 'BioPhenics' project, plans to use cell biology and microscopic imaging to advance cancer drug discovery. The project will initially focus on breast and lung cancer, GE Healthcare said.
Institut Curie will use the IN Cell Analyzer to observe cells in culture in order to study cellular behavior and responses. GE Healthcare said that the institute will use the system for a range of biological applications, including screening, lead profiling, target validation, and assay development.
Financial terms of the agreement were not provided.